These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33601139)

  • 1. Antibacterial activity of a new monocarbonyl analog of curcumin MAC 4 is associated with divisome disruption.
    Polaquini CR; Marques BC; Ayusso GM; Morão LG; Sardi JCO; Campos DL; Silva IC; Cavalca LB; Scheffers DJ; Rosalen PL; Pavan FR; Ferreira H; Regasini LO
    Bioorg Chem; 2021 Apr; 109():104668. PubMed ID: 33601139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of 3,3'-dihydroxycurcumin (DHC) is associated with membrane perturbation.
    Polaquini CR; Morão LG; Nazaré AC; Torrezan GS; Dilarri G; Cavalca LB; Campos DL; Silva IC; Pereira JA; Scheffers DJ; Duque C; Pavan FR; Ferreira H; Regasini LO
    Bioorg Chem; 2019 Sep; 90():103031. PubMed ID: 31238181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified curcumin targets the membrane of Bacillus subtilis.
    Morão LG; Polaquini CR; Kopacz M; Torrezan GS; Ayusso GM; Dilarri G; Cavalca LB; Zielińska A; Scheffers DJ; Regasini LO; Ferreira H
    Microbiologyopen; 2019 Apr; 8(4):e00683. PubMed ID: 30051597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial effects of curcumin: An in vitro minimum inhibitory concentration study.
    Gunes H; Gulen D; Mutlu R; Gumus A; Tas T; Topkaya AE
    Toxicol Ind Health; 2016 Feb; 32(2):246-50. PubMed ID: 24097361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Carbocyclic Curcumin Inhibits Proliferation of Gram-Positive Bacteria by Targeting FtsZ.
    Groundwater PW; Narlawar R; Liao VW; Bhattacharya A; Srivastava S; Kunal K; Doddareddy M; Oza PM; Mamidi R; Marrs EC; Perry JD; Hibbs DE; Panda D
    Biochemistry; 2017 Jan; 56(3):514-524. PubMed ID: 28002947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the binding site of curcumin in Escherichia coli and Bacillus subtilis FtsZ--a structural insight to unveil antibacterial activity of curcumin.
    Kaur S; Modi NH; Panda D; Roy N
    Eur J Med Chem; 2010 Sep; 45(9):4209-14. PubMed ID: 20615583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis.
    Baldwin PR; Reeves AZ; Powell KR; Napier RJ; Swimm AI; Sun A; Giesler K; Bommarius B; Shinnick TM; Snyder JP; Liotta DC; Kalman D
    Eur J Med Chem; 2015 Mar; 92():693-9. PubMed ID: 25618016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of new structural class of semisynthetic molecule, triphenyl-phosphonium conjugated diarylheptanoid.
    Kumari S; Jayakumar S; Gupta GD; Bihani SC; Sharma D; Kutala VK; Sandur SK; Kumar V
    Free Radic Biol Med; 2019 Nov; 143():140-145. PubMed ID: 31398499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of a structurally new class of antibacterial compound, triphenyl-phosphonium conjugated diarylheptanoid: Antibacterial activity and molecular mechanism.
    Kumari S; Jayakumar S; Bihani SC; Shetake N; Naidu R; Kutala VK; Sarma HD; Gupta GD; Sandur SK; Kumar V
    J Biosci; 2020; 45():. PubMed ID: 33410424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced efficacy of a Cu
    Kumar P; Saha T; Behera S; Gupta S; Das S; Mukhopadhyay K
    J Inorg Biochem; 2021 Sep; 222():111494. PubMed ID: 34091095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliminating the heart from the curcumin molecule: monocarbonyl curcumin mimics (MACs).
    Shetty D; Kim YJ; Shim H; Snyder JP
    Molecules; 2014 Dec; 20(1):249-92. PubMed ID: 25547726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance.
    Revalde JL; Li Y; Hawkins BC; Rosengren RJ; Paxton JW
    Biochem Pharmacol; 2015 Feb; 93(3):305-17. PubMed ID: 25543853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity.
    Rai D; Singh JK; Roy N; Panda D
    Biochem J; 2008 Feb; 410(1):147-55. PubMed ID: 17953519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photo-enhanced antibacterial activity of polydopamine-curcumin nanocomposites with excellent photodynamic and photothermal abilities.
    Su R; Yan H; Li P; Zhang B; Zhang Y; Su W
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102417. PubMed ID: 34186263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer perspectives of monocarbonyl analogs of curcumin: A decade (2014-2024) review.
    Nagargoje AA; Deshmukh TR; Shaikh MH; Khedkar VM; Shingate BB
    Arch Pharm (Weinheim); 2024 Sep; 357(9):e2400197. PubMed ID: 38895952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationally designed curcumin based ruthenium(ii) antimicrobials effective against drug-resistant Staphylococcus aureus.
    Srivastava P; Shukla M; Kaul G; Chopra S; Patra AK
    Dalton Trans; 2019 Aug; 48(31):11822-11828. PubMed ID: 31215556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant, antibacterial and anti-cancer activities of β-and γ-CDs/curcumin loaded in chitosan nanoparticles.
    Alizadeh N; Malakzadeh S
    Int J Biol Macromol; 2020 Mar; 147():778-791. PubMed ID: 31982535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial Activity of Isobavachalcone (IBC) Is Associated with Membrane Disruption.
    Assis LR; Theodoro RDS; Costa MBS; Nascentes JAS; Rocha MDD; Bessa MAS; Menezes RP; Dilarri G; Hypolito GB; Santos VRD; Duque C; Ferreira H; Martins CHG; Regasini LO
    Membranes (Basel); 2022 Feb; 12(3):. PubMed ID: 35323743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial evaluation and mode of action study of BIMQ, a novel bacterial cell division inhibitor.
    Sun N; Li M; Cai S; Li Y; Chen C; Zheng Y; Li X; Fang Z; Lv H; Lu YJ
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1224-1230. PubMed ID: 31109649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.